MUSOLINO, Antonino
 Distribuzione geografica
Continente #
EU - Europa 54
AS - Asia 24
NA - Nord America 21
Totale 99
Nazione #
IT - Italia 22
US - Stati Uniti d'America 19
IE - Irlanda 14
IN - India 14
FR - Francia 6
CN - Cina 4
RO - Romania 4
CZ - Repubblica Ceca 3
DE - Germania 2
ES - Italia 2
KR - Corea 2
PK - Pakistan 2
CA - Canada 1
HN - Honduras 1
PH - Filippine 1
RS - Serbia 1
VN - Vietnam 1
Totale 99
Città #
Dublin 14
Mumbai 10
Ashburn 3
Milan 3
Broken Arrow 2
Hangzhou 2
Karachi 2
Mysore 2
Rome 2
Sassuolo 2
Seoul 2
Vilanova i la Geltrú 2
Ann Arbor 1
Belgrade 1
Belpasso 1
Bengaluru 1
Boardman 1
Bremen 1
Buffalo 1
Casina 1
Crotone 1
Dong Ket 1
Fleming Island 1
Lawrenceville 1
Manassas 1
Naples 1
Parma 1
Parsippany 1
Pune 1
Quezon City 1
San Piero A Sieve 1
Shanghai 1
Tegucigalpa 1
Vedelago 1
Wuhan 1
Totale 69
Nome #
Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial, file e177fbc7-1531-50b0-e053-d805fe0adaee 58
Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective Study, file e177fbc7-a397-50b0-e053-d805fe0adaee 16
Salivary microRNA for diagnosis of cancer and systemic diseases: A systematic review, file e177fbc7-6a99-50b0-e053-d805fe0adaee 14
La fototerapia mirata bath-puva come trattamento di alcune reazioni cutanee avverse causte da farmaci inibitori delle tirosina-Kinasi (TKI), file e177fbc4-2e00-50b0-e053-d805fe0adaee 9
Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma, file 9dd76aa2-b75f-4677-a83e-b7095c78021c 2
Hypertriglyceridaemia with bexarotene in cutaneous T-cell lymphoma: The role of omega-3 fatty acids., file e177fbc4-180a-50b0-e053-d805fe0adaee 1
Totale 100
Categoria #
all - tutte 298
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 298


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 3 0 2
2021/202221 0 0 3 1 3 4 4 0 2 0 4 0
2022/202333 1 0 0 1 1 3 2 0 17 3 5 0
2023/202431 6 0 0 3 5 7 7 3 0 0 0 0
Totale 100